3,559
Views
21
CrossRef citations to date
0
Altmetric
Special Review: IL-6 inhibitor

Interleukin-6 in juvenile idiopathic arthritis

Pages 275-286 | Received 12 Nov 2018, Accepted 24 Jan 2019, Published online: 08 Mar 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Takeo Hata, Atsushi Hirata, Ryosuke Ota, Keiko Hosohata, Masami Nishihara, Masashi Neo & Takahiro Katsumata. (2022) Biologic Disease-Modifying and Other Anti-Rheumatic Drugs Use in Patients with Moderate-to-Severe Juvenile Idiopathic Arthritis Based on a Japanese Nationwide Claims Database. Therapeutics and Clinical Risk Management 18, pages 843-853.
Read now
Frideriki Poutoglidou, Chryssa Pourzitaki, Maria Eleni Manthou, Efthimios Samoladas, Athanasios Saitis, Foteini Malliou & Dimitrios Kouvelas. (2022) The inhibitory effect of tocilizumab on systemic bone loss and tendon inflammation in a juvenile Collagen-Induced arthritis rat model. Connective Tissue Research 63:6, pages 577-589.
Read now
Rolando Cimaz, Gabriella Maioli & Giulia Calabrese. (2020) Current and emerging biologics for the treatment of juvenile idiopathic arthritis. Expert Opinion on Biological Therapy 20:7, pages 725-740.
Read now

Articles from other publishers (18)

Andreas Elfving, Arja Harila-Saari, Ludwig Nilsson & Lillemor Berntson. (2023) An explorative study on proteomic analyses related to inflammation and pain in children with juvenile idiopathic arthritis. BMC Pediatrics 23:1.
Crossref
Sara L. Davis, Mary Latimer & Marti Rice. (2023) Biomarkers of Stress and Inflammation in Children. Biological Research For Nursing, pages 109980042311688.
Crossref
Rahul Gawri, Yian Khai Lau, Gloria Lin, Snehal S. Shetye, Chenghao Zhang, Zhirui Jiang, Khaled Abdoun, Carla R. Scanzello, Stephanie Y. Jo, Wilfried Mai, George R. Dodge, Margret L. Casal & Lachlan J. Smith. (2023) Dose-dependent effects of enzyme replacement therapy on skeletal disease progression in mucopolysaccharidosis VII dogs. Molecular Therapy - Methods & Clinical Development 28, pages 12-26.
Crossref
Saverio La Bella, Marta Rinaldi, Armando Di Ludovico, Giulia Di Donato, Giulio Di Donato, Vincenzo Salpietro, Francesco Chiarelli & Luciana Breda. (2023) Genetic Background and Molecular Mechanisms of Juvenile Idiopathic Arthritis. International Journal of Molecular Sciences 24:3, pages 1846.
Crossref
Eugen Feist & Evgeny Nasonov. (2023) Interleukin 6 Inhibition in Rheumatoid Arthritis: Highlight on Olokizumab. Rheumatology 2:1, pages 17.
Crossref
E. L. Nasonov & Eugen Feist. (2022) The prospects of interleukin-6 inhibition in rheumatoid arthritis: Olokizumab (novel monoclonal antibodies to IL-6). Rheumatology Science and Practice 60:5, pages 505-518.
Crossref
Shuai Liu, Weiming Gong, Lu Liu, Ran Yan, Shukang Wang & Zhongshang Yuan. (2022) Integrative Analysis of Transcriptome-Wide Association Study and Gene-Based Association Analysis Identifies In Silico Candidate Genes Associated with Juvenile Idiopathic Arthritis. International Journal of Molecular Sciences 23:21, pages 13555.
Crossref
Eduardo Tuta Quintero, Angela C. Mosquera Pongutá, Erika Alexandra Barroso da Silva, Juan Olivella, Andrea Alexandra Silvera, Camila Aragón, Lorena Vásquez, Estefanía Collazos, Karla Olivares Vigles, Karol Martínez, Mateo León Machicado, Yeimy N. Díaz Pérez & Juan Pimentel. (2022) SARS-CoV-2 y síndrome post-COVID-19 en reumatología pediátrica: una revisión exploratoria. Revista Colombiana de Reumatología.
Crossref
Laura Marinela Ailioaie, Constantin Ailioaie & Gerhard Litscher. (2022) Biomarkers in Systemic Juvenile Idiopathic Arthritis, Macrophage Activation Syndrome and Their Importance in COVID Era. International Journal of Molecular Sciences 23:21, pages 12757.
Crossref
Magdalena Wojdas, Klaudia Dąbkowska, Kornelia Kuźnik-Trocha, Grzegorz Wisowski, Iwona Lachór-Motyka, Katarzyna Komosińska-Vassev, Krystyna Olczyk & Katarzyna Winsz-Szczotka. (2022) Plasma Glycosaminoglycans in Children with Juvenile Idiopathic Arthritis Being Treated with Etanercept as Potential Biomarkers of Joint Dysfunction. Biomedicines 10:8, pages 1845.
Crossref
Tiago Borges, Arsénio Barbosa & Sérgio Silva. 2022. Translational Autoimmunity. Translational Autoimmunity 83 114 .
Boris Hügle, Manuela Krumrey-Langkammerer & Johannes-Peter Haas. (2021) Infection with SARS-CoV-2 causes flares in patients with juvenile idiopathic arthritis in remission or inactive disease on medication. Pediatric Rheumatology 19:1.
Crossref
T.P. Borysova, S.V. Samsonenko, L.I. Vakulenko & O.O. Makoviichuk. (2021) Гломерулярные поражения почек у детей с ювенильным ревматоидным артритом (обзор литературы). KIDNEYS 10:1, pages 42-47.
Crossref
Jorge Domínguez-Andrés, Yunus Kuijpers, Olivier B Bakker, Martin Jaeger, Cheng-Jian Xu, Jos WM Van der Meer, Mattias Jakobsson, Jaume Bertranpetit, Leo AB Joosten, Yang Li & Mihai G Netea. (2021) Evolution of cytokine production capacity in ancient and modern European populations. eLife 10.
Crossref
Chao-Yi Wu, Huang-Yu Yang, Jing-Long Huang & Jenn-Haung Lai. (2021) Signals and Mechanisms Regulating Monocyte and Macrophage Activation in the Pathogenesis of Juvenile Idiopathic Arthritis. International Journal of Molecular Sciences 22:15, pages 7960.
Crossref
Kristina Ritter, Jasmin Rousseau & Christoph Hölscher. (2020) The Role of gp130 Cytokines in Tuberculosis. Cells 9:12, pages 2695.
Crossref
Enas Noor-eldeen, Waleed A. Hassan, Eman G. Behiry & Abd El-hameed Abd El-monem. (2020) Serum, synovial and mRNA expression of interleukin-33 in juvenile idiopathic arthritis patients: Potential role as a marker of disease activity and relation to musculoskeletal ultrasound. The Egyptian Rheumatologist 42:3, pages 225-230.
Crossref
. (2020) Recurrent Breast Cancer – Hyperbaric Oxygen Therapy. Medical & Clinical Research 5:5.
Crossref